Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An overview of the EORTC Breast Cancer Cooperative Group's activities.
Paridaens R, Mattheiem WH, van Dongen JA, Mouridsen HT, Rotmensz N, Sylvester R. Paridaens R, et al. Among authors: van dongen ja. Eur J Cancer Clin Oncol. 1983 Dec;19(12):1665-9. doi: 10.1016/0277-5379(83)90149-9. Eur J Cancer Clin Oncol. 1983. PMID: 6363087 Clinical Trial. No abstract available.
Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J, et al. van Dongen JA, et al. Among authors: van der schueren e. Eur J Cancer. 1992;28A(4-5):801-5. doi: 10.1016/0959-8049(92)90118-l. Eur J Cancer. 1992. PMID: 1524898 Clinical Trial.
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F, Sylvester R, Fentiman IS, van der Schueren E, van Zijl K, Blichert-Toft M, Bartelink H, van Dongen JA. van Tienhoven G, et al. Among authors: van zijl k, van der schueren e, van dongen ja. Eur J Cancer. 1999 Jan;35(1):32-8. doi: 10.1016/s0959-8049(98)00301-3. Eur J Cancer. 1999. PMID: 10211085
Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, Van Dongen JA. Julien JP, et al. Among authors: van dongen ja. Lancet. 2000 Feb 12;355(9203):528-33. doi: 10.1016/s0140-6736(99)06341-2. Lancet. 2000. PMID: 10683002 Clinical Trial.
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.
Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, van Tienhoven G, Andersen KW, Sylvester RJ, van Dongen JA; Danish Breast Cancer Cooperative Group. Breast Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. Voogd AC, et al. Among authors: van dongen ja, van tienhoven g. J Clin Oncol. 2001 Mar 15;19(6):1688-97. doi: 10.1200/JCO.2001.19.6.1688. J Clin Oncol. 2001. PMID: 11250998
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.
van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H. van Dongen JA, et al. Among authors: van zijl k, van der schueren e. J Natl Cancer Inst. 2000 Jul 19;92(14):1143-50. doi: 10.1093/jnci/92.14.1143. J Natl Cancer Inst. 2000. PMID: 10904087 Clinical Trial.
176 results